Abstract:Introduction: The looming antibiotic-resistance problem has imposed an enormous crisis on global public health and agricultural development. Even worse, the evolution and widespread distribution of antibiotic-resistance elements in bacterial pathogens have made the resurgence of diseases that were once easily treatable deadly again. The development of antibiotics with novel mechanisms of action is urgently required. Objectives: Inspired by charming activity-based protein profiling (ABPP) technology and increasing attention to quinazolines in the development of antibacterial agents, this study engineered a series of new quinazoline derivatives, assessed their antibacterial profiles, and first identified the possible target. Methods: The target identification and their possible binding sites were verified by ABPP technology, molecular docking, and molecular dynamic simulations. The fatty acid synthesis process was analyzed by gas chromatography, propidium iodide staining, and scanning electron microscopy. The physicochemical properties and fungicide-likeness were evaluated using the Fungicide Physicochemical-properties Analysis Database. Results: Compound 7a, an acrylamide-functionalized quinazoline derivative, exhibited excellent antibacterial potency against Xanthomonas oryzae pv. oryzae with an EC50 value of 13.20 µM. More importantly, ABPP technology showed that β-ketoacyl-ACP-synthase Ⅱ (FabF) was the first identified quinazolines' potential target. Compound 7a could selectively bind to the Cys151 residue of FabF through covalent interaction, suppress fatty acid biosynthesis, and damage the cell membrane integrity, thereby killing the bacteria. The pot experiment results showed that compound 7a demonstrated protective and curative values of 49.55 % and 47.46 %, surpassing controls bismerthiazol and thiodiazole copper. Finally, compound 7a exhibited low toxicity towards non-target organisms. These unprecedented performances contributed to excavating new quinazoline-based bactericidal agents. Conclusion: Our research highlights the superiority of ABPP technology, for the first time, identifies the target of engineered quinazolines in pathogenic bacteria, and their potential target fished by ABPP tools holds great promise for the development of quinazoline-based and/or FabF-targeted bactericides.

Expanding the Bioactive Chemical Space of Anthrabenzoxocinones Through Engineering the Highly Promiscuous Biosynthetic Modification Steps.

Synthesis and antibacterial activity of novel icariin derivatives.

Total Synthesis of Three Families of Natural Antibiotics: Anthrabenzoxocinones, Fasamycins/Naphthacemycins, and Benastatins

Synthetic Optimization and Antibacterial Activity of Novel Benzodioxepine-Biphenyl Amide Derivatives

Structures, Biosynthesis and Biological Activities of Benastatins, Anthrabenzoxocinones and Fredericamycins

Asymmetric total synthesis of polycyclic xanthenes and discovery of a WalK activator active against MRSA

A Novel Chemical Biology and Computational Approach to Expedite the Discovery of New-Generation Polymyxins Against Life-Threatening Acinetobacter Baumannii

Establishing the Comprehensive Structure−Activity Relationship of the Natural Antibiotic Kibdelomycin/Amycolamicin

An Improved Antibacterial Activity of Cephalosporin Analogues by Introducing Sulfamoylamino Group

An Unusual Aromatase/cyclase Programs the Formation of the Phenyldimethylanthrone Framework in Anthrabenzoxocinones and Fasamycin.

Isolation of an Anthrabenzoxocinone 1.264-C from Streptomyces Sp. FXJ1.264 and Absolute Configuration Determination of the Anthrabenzoxocinones

Activity-based protein profiling guided new target identification of quinazoline derivatives for expediting bactericide discovery: Activity-based protein profiling derived new target discovery of antibacterial quinazolines

Expanding the Chemical Diversity of Fasamycin Via Genome Mining and Biocatalysis

Rational engineering of amide synthetase enables bioconversion to diverse xiamenmycin derivatives.

Design, Synthesis and Antimicrobial Evaluation of Novel Benzoxazole Derivatives.

Design, synthesis and antibacterial evaluation of a novel series of biaryloxazolidinone derivatives against Gram-positive bacteria

Design, Synthesis and Structure-activity Relationships of Novel Non-ketolides: 9-Oxime Clarithromycin Featured with Seven- to Thirteen-atom-length Diamine Linkers at 3-OH

Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics

An unusual aromatase/cyclase programs the formation of the phenyldimethylanthrone framework in anthrabenzoxocinones and fasamycin

Synthesis and structure-activity relationship studies of novel [6,6,5] tricyclic oxazolidinone derivatives as potential antibacterial agents.

Discovery of Natural Sesquiterpene Lactone 1- O -Acetylbritannilactone Analogues Bearing Oxadiazole, Triazole, or Imidazole Scaffolds for the Development of New Fungicidal Candidates.